Preclinical Phase 1 Phase 2 Phase 3
Ozarelix:
Spectrum Pharmaceuticals
world (ex-Japan, Korea and ex-other Asian countries)

Nippon Kayaku
Japan for oncology indications

Handok Pharmaceuticals
Korea and other Asian countries for BPH indication

Perifosine:
Yakult Honsha
Japan

Handok Pharmaceuticals
Korea

Hikma Pharmaceuticals
Middle East/North Africa

Zoptarelin Doxorubicin:
Synopharm A-Think
China, Hong Kong and Macau for endometrial cancer indication

Oncology Oncology Endocrine Therapy Endocrine Therapy